News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

Friends and Family

25% Off

the purchase of 3 or more products

Shop

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
5-Methylcytosine (5-mC) (D3S2Z) Rabbit mAb 28692 20 µl
Immunofluorescence
All Rabbit IgG
5-Hydroxymethylcytosine (5-hmC) (HMC31) Mouse mAb 51660 20 µl
Immunofluorescence
All Mouse IgG1
5-Carboxylcytosine (5-caC) (D7S8U) Rabbit mAb 36836 20 µl
Immunofluorescence
All Rabbit IgG
5-Formylcytosine (5-fC) (D5D4K) Rabbit mAb 74178 20 µl
Immunofluorescence
All Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
Goat 
Anti-mouse IgG, HRP-linked Antibody 7076 100 µl
Western Blotting
Horse 

Product Description

The DNA Cytosine Modification Antibody Sampler Kit provides an economical means of detecting the levels of cytosine modifications in DNA by dot blot using antibodies against 5-methylcytosine, 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine.


Specificity / Sensitivity

5-Methylcytosine (5-mC) (D3S2Z) Rabbit mAb recognizes endogenous levels of 5-methylcytosine. 5-Hydroxymethylcytosine (5-hmC) (HMC31) Mouse mAb recognizes endogenous levels of 5-hydroxymethylcytosine. 5-Formylcytosine (5-fC) (D5D4K) Rabbit mAb recognizes transfected levels of 5-formylcytosine. 5-Caroxylcytosine (5-caC) (D7S8U) Rabbit mAb recognizes transfected levels of 5-methylcytosine. These antibodies have been validated using ELISA and dot blot, and cross-reactivity was not observed with other marks. Many cells and tissues contain very low endogenous levels of 5-hmC, 5-fC, and 5-caC that may fall below the detection limits of these antibodies.


Source / Purification

Monoclonal antibodies are produced by immunizing animals with 5-methylcytidine, 5-hydroxymethylcytidine, 5-formyl-2'-deoxycytosine, or 5-carboxylcytidine.

Methylation of DNA at cytosine residues is a heritable, epigenetic modification that is critical for proper regulation of gene expression, genomic imprinting, and mammalian development (1,2). 5-methylcytosine is a repressive epigenetic mark established de novo by two enzymes, DNMT3a and DNMT3b, and is maintained by DNMT1 (3, 4). 5-methylcytosine was originally thought to be passively depleted during DNA replication. However, subsequent studies have shown that Ten-Eleven Translocation (TET) proteins TET1, TET2, and TET3 can catalyze the oxidation of methylated cytosine to 5-hydroxymethylcytosine (5-hmC) (5). Additionally, TET proteins can further oxidize 5-hmC to form 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), both of which are excised by thymine-DNA glycosylase (TDG), effectively linking cytosine oxidation to the base excision repair pathway and supporting active cytosine demethylation (6,7).


TET protein-mediated cytosine hydroxymethylation was initially demonstrated in mouse brain and embryonic stem cells (5, 8). Since then this modification has been discovered in many tissues, with the highest levels found in the brain (9). While 5-fC and 5-caC appear to be short-lived intermediate species, there is mounting evidence showing that 5-hmC is a distinct epigenetic mark with various unique functions (10,11). The modified base itself is stable in vivo and interacts with various readers, including MeCP2 (11,12). The global level of 5-hmC increases during brain development and 5-hmC is enriched at promoter regions and poised enhancers. Furthermore, there is an inverse correlation between levels of 5-hmC and histone H3K9 and H3K27 trimethylation, suggesting a role for 5-hmC in gene activation (12). Lower amounts of 5-hmC have been reported in various cancers, including myeloid leukemia and melanoma (13,14).


1.  Hermann, A. et al. (2004) Cell Mol Life Sci 61, 2571-87.

2.  Turek-Plewa, J. and Jagodziński, P.P. (2005) Cell Mol Biol Lett 10, 631-47.

3.  Okano, M. et al. (1999) Cell 99, 247-57.

4.  Li, E. et al. (1992) Cell 69, 915-26.

5.  Tahiliani, M. et al. (2009) Science 324, 930-5.

6.  He, Y.F. et al. (2011) Science 333, 1303-7.

7.  Ito, S. et al. (2011) Science 333, 1300-3.

8.  Kriaucionis, S. and Heintz, N. (2009) Science 324, 929-30.

9.  Globisch, D. et al. (2010) PLoS One 5, e15367.

10.  Gao, Y. et al. (2013) Cell Stem Cell 12, 453-69.

11.  Mellén, M. et al. (2012) Cell 151, 1417-30.

12.  Wen, L. et al. (2014) Genome Biol 15, R49.

13.  Delhommeau, F. et al. (2009) N Engl J Med 360, 2289-301.

14.  Lian, C.G. et al. (2012) Cell 150, 1135-46.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

97763
DNA Cytosine Modification Antibody Sampler Kit